1.
Kudchadkar R, Chang ALS. Long-Term Safety of Sonidegib in Basal Cell Carcinoma: 30-Month Results from the BOLT Trial. J of Skin [Internet]. 2018Feb.23 [cited 2022Oct.6];2(S1):S47. Available from: https://www.jofskin.org/index.php/skin/article/view/303